A+H双上市
Search documents
特锐德(300001.SZ)冲刺A+H双上市
Xin Lang Cai Jing· 2026-02-27 04:53
览富财经网讯:2月26日,青岛特锐德电气股份有限公司(简称:特锐德,300001.SZ)递表港交所拟主 板IPO。 | 最新發佈 日期 | 申請人 | | --- | --- | | 26/02/2026 | 青島特銳德電氣股份有限公司 | | | 26/02/2026 整體協調人公告一委任 四 | | | 26/02/2026 申請版本 (第一次呈交) 全文檔案 四川多檔案 》 | 据了解,特锐德是全球最大的高压预制舱变电站制造商与中国最大的电动汽车充电设备提供商及充电网 运营商。公司的业务覆盖高压及中压预制舱变电站、变压器、开关设备和电动汽车充电设备的研发、制 造及销售,以及电动汽车充电网的建设和运营。 近年来,特锐德实现了稳健的增长。公司的总收入由2023年的人民币12,690.6百万元增加21.1%至2024 年的人民币15,374.5百万元,以及从截至2024年10月31日止十个月的人民币10,425.8百万元增加8.7%至 2025年同期的人民币11,328.7百万元。净利润由2023年的人民币526.8百万元增加78.3%至2024年的人民 币939.4百万元,再从截至2024年10月31日止十 ...
今日登陆港交所,东鹏饮料迈向 A+H 新征程
Xin Lang Cai Jing· 2026-02-03 10:29
Core Viewpoint - Dongpeng Beverage has officially listed on the Hong Kong Stock Exchange, becoming the first functional beverage company in China to achieve a dual listing (A+H), marking a significant milestone in its global expansion strategy [1][8]. Group 1: Financial Performance - Dongpeng Beverage is projected to achieve a revenue of over 20.76 billion yuan in 2025, representing a year-on-year growth of over 31%. The net profit is expected to reach between 4.34 billion and 4.59 billion yuan, with an increase of over 30% [3]. - The company has consistently outperformed the industry in terms of revenue and profit, showcasing strong internal growth momentum [3]. Group 2: Market Strategy and Channel Development - Dongpeng has established a comprehensive sales network covering nearly 100% of China's prefecture-level cities, with over 3,200 distributors and 4.3 million active terminals, reaching over 250 million consumers [3]. - The company employs refined channel management to ensure efficient product distribution across the national market, which serves as a core competitive advantage against industry fluctuations [3]. Group 3: Product Innovation and Diversification - Dongpeng's "1+6" strategy centers around its flagship product, Dongpeng Special Drink, while simultaneously nurturing six potential product categories. The electrolyte drink "Bushi La" has seen remarkable growth, with revenue soaring to 2.847 billion yuan in the first three quarters of 2025, a year-on-year increase of 134.8% [3]. - The company is also responding to evolving consumer health trends by launching a zero-sugar, zero-fat version of Dongpeng Special Drink, targeting health-conscious consumers [5]. Group 4: Global Expansion - The recent listing on the Hong Kong Stock Exchange is a crucial step in Dongpeng's global strategy, with a clear path to international markets by focusing on cost-effectiveness and cultural branding [7]. - Dongpeng's products are currently exported to over 30 countries and regions, with operational subsidiaries in Indonesia and Vietnam, and the raised funds will enhance production capacity and supply chain upgrades to support global development [7].
东鹏饮料港交所正式上市,成国内首家A+H双上市功能饮料企业
Quan Jing Wang· 2026-02-03 08:55
作为中国功能饮料赛道的领军企业,东鹏饮料始终精准把握行业发展趋势,紧扣消费市场健康化、细分 化的核心需求,构建起多元化的产品矩阵,推行"1+6"多品类发展战略,在巩固能量饮料核心优势的同 时,持续培育第二增长曲线,产品结构优化成效显著。旗下拳头产品东鹏特饮凭借深入人心的品牌价值 与深度的渠道渗透能力,表现尤为亮眼,连续4年(2021-2024)位居中国功能饮料销量榜首,2025年前 三季度,其收入达到125.63亿元,同比增幅接近20%,在中国百亿单品中增速位居前列。 而上市仅三年的东鹏补水啦,更是实现了跨越式增长,该产品自2023年1月推出后增速迅猛,2025年上 半年收入14.93亿元,追平2024年全年,前三季度累计收入达28.47亿元。东鹏补水啦以"快速补电解 质"为核心定位抢占运动场景赛道,据尼尔森数据显示,按营收规模已成为中国电解质饮料第一品牌, 成为企业业绩增长的全新引擎。此外,东鹏饮料还着眼于大众日常饮用与多元化消费需求,持续推出果 之茶、港氏奶茶等新品类,以产品创新引领消费潮流,展现出强劲的品牌生命力。 2月3日,东鹏饮料正式登陆香港联合交易所主板,证券简称为"东鹏饮料",股份代码09980 ...
东鹏饮料A+H双上市,东方大鹏携飞跃全球使命拓疆前行
Sou Hu Cai Jing· 2026-02-03 08:53
Core Viewpoint - Dongpeng Beverage has officially listed on the Hong Kong Stock Exchange, becoming the first functional beverage company in China to achieve A+H dual listing, marking a significant milestone in its capital layout and a new phase in its global development [1][7]. Group 1: Product and Performance - Dongpeng Beverage has established a diversified product matrix and a "1+6" multi-category development strategy, maintaining its core advantage in energy drinks while cultivating a second growth curve [3]. - The flagship product, Dongpeng Special Drink, has ranked first in China's functional beverage sales for four consecutive years (2021-2024), with revenue reaching 12.563 billion yuan in the first three quarters of 2025, showing a nearly 20% year-on-year increase [3][5]. - The newly launched Dongpeng Water has seen rapid growth, achieving 1.493 billion yuan in revenue in the first half of 2025, matching the total revenue for 2024, and reaching 2.847 billion yuan in the first three quarters [3][5]. Group 2: Financial Performance - Dongpeng Beverage's revenue and profit have consistently led the industry, with a forecasted annual revenue of over 20.76 billion yuan for 2025, representing a year-on-year growth of over 31%, and a net profit estimated between 4.34 billion to 4.59 billion yuan, with a growth rate of 30.46% to 37.97% [5]. - The company's strong financial performance reflects the effectiveness of its product strategy and market positioning, providing a solid foundation for long-term sustainable growth [5]. Group 3: Channel and Capacity - Dongpeng Beverage has built a comprehensive sales network covering nearly 100% of China's prefecture-level cities, supported by over 3,200 distributors and 4.3 million active terminal points, reaching over 250 million unique consumers [6]. - The company has established production bases across multiple regions, with 10 bases already operational and a new base in Chengdu signed on January 23, 2026, demonstrating a robust national capacity layout [6]. Group 4: Globalization Strategy - The A+H dual listing is a key step in Dongpeng Beverage's globalization strategy, providing broader financing channels and enhancing its international brand influence [7]. - The company has already begun its global expansion, exporting products to over 30 countries and regions, with subsidiaries in Indonesia and Vietnam operational [7]. - Funds raised from the listing will focus on enhancing production capacity and supply chain upgrades, supporting its global expansion efforts [7]. Group 5: Conclusion - The successful A+H dual listing of Dongpeng Beverage not only marks an important milestone for the company but also serves as a declaration for Chinese functional beverage brands to enter the global market [8]. - The company aims to leverage its dual capital advantages to lead the domestic market while deepening its global production, channel, and brand layout [8].
登陆港股,东方大鹏飞跃全球正当时
Cai Fu Zai Xian· 2026-02-03 07:48
Core Viewpoint - Dongpeng Beverage has officially listed on the Hong Kong Stock Exchange, becoming the first functional beverage company in China to achieve a dual listing in both A-shares and H-shares, marking a significant step in its global expansion strategy [2][9] Group 1: Company Overview - Dongpeng Beverage is a leading player in the functional beverage sector in China, focusing on health-oriented and segmented consumer demands through a diversified product matrix and a "1+6" multi-category strategy [3] - The flagship product "Dongpeng Special Drink" has topped the sales charts in China's energy drink market, while the newly launched "Dongpeng Water" has generated revenue of 2.847 billion yuan in the first three quarters of 2025, marking a 134.78% year-on-year growth and establishing it as the leading brand in China's electrolyte beverage sector [5] Group 2: Financial Performance - The company forecasts a total revenue of over 20.76 billion yuan for the year 2025, representing a growth of over 31%, with net profit expected to be between 4.34 billion and 4.59 billion yuan, reflecting a year-on-year increase of 30.46% to 37.97% [5] - Dongpeng Beverage has consistently maintained high growth rates in revenue and profit from 2022 to 2025, demonstrating strong internal development momentum that underpins its long-term stability and attractiveness to global capital [6] Group 3: Distribution and Market Strategy - The company has established a comprehensive sales network covering nearly 100% of China's prefecture-level cities, with over 3,200 distributors and 4.3 million active retail outlets, reaching more than 250 million unique consumers [6] - This extensive and deep penetration of the distribution network not only facilitates product sales and market expansion but also serves as a core competitive advantage for the company in navigating industry fluctuations [6] Group 4: Global Expansion - The listing on the Hong Kong Stock Exchange is a crucial step in Dongpeng Beverage's globalization strategy, providing significant support for its international expansion efforts [7] - The company has already exported products to over 30 countries and regions, with operational subsidiaries in Indonesia and Vietnam, and plans to use the funds raised from the listing to enhance production capacity and supply chain upgrades [7]
1460亿,红牛最大对手今天IPO了
Sou Hu Cai Jing· 2026-02-03 04:36
Core Viewpoint - Dongpeng Beverage has successfully listed on the Hong Kong Stock Exchange, marking a significant step in its internationalization strategy and becoming the first "A+H" dual-listed functional beverage company in China [2][11]. Company Overview - Dongpeng Beverage, known for its core product "Dongpeng Special Drink," has achieved annual revenue exceeding 10 billion yuan and has established itself as a national brand deeply rooted in county-level markets [2]. - The company has maintained its position as the top functional beverage brand in China by sales volume for four consecutive years since 2021, according to a report by Frost & Sullivan [2]. IPO Details - The IPO attracted a "super luxurious" lineup of cornerstone investors, with over $600 million in subscriptions from more than ten top global investment institutions, setting a record for the number of cornerstone investors in the Hong Kong consumer sector [3]. - On its first trading day, Dongpeng's shares opened at 257 HKD per share, giving it a total market capitalization of approximately 146 billion HKD [2]. Leadership and Strategy - Lin Muqin, the founder and chairman of Dongpeng, has played a crucial role in the company's transformation from a struggling state-owned enterprise to a market leader in functional beverages [5][10]. - The company's strategic focus on functional drinks, particularly the "Dongpeng Special Drink," has allowed it to capture a significant market share by targeting the price-sensitive consumer segment left by competitors like Red Bull [6][9]. Market Position and Growth - Dongpeng Beverage has established a robust sales network covering over 4.3 million retail outlets across China, achieving nearly 100% coverage of all prefecture-level cities [9]. - As of September 30, 2025, Dongpeng's market share in the functional beverage sector has grown from 15% in 2021 to 26.3% in 2024, making it the second-largest company by retail value and the largest by sales volume in the market [9][12]. Financial Performance - For the first three quarters of 2025, Dongpeng reported total revenue of 16.844 billion yuan, a year-on-year increase of 34.13%, with a net profit of 3.761 billion yuan, up 38.91% [12]. - The revenue contribution from the "Dongpeng Special Drink" has decreased to approximately 74.6%, while the newly launched "Dongpeng Water" has seen significant growth, contributing 2.847 billion yuan, or 16.9% of total revenue, with a year-on-year increase of over 134% [12][13]. Future Outlook - The dual listing on the Hong Kong Stock Exchange is expected to provide Dongpeng with broader development opportunities and financing channels for future global competition and product diversification [11][17]. - The company's strategy includes expanding into various beverage categories, such as electrolyte drinks and tea, while maintaining a focus on its core product line [15].
仙乐健康(300791.SZ) 冲刺A+H双上市
Sou Hu Cai Jing· 2026-01-30 02:52
览富财经网讯:1月29日,仙乐健康科技股份有限公司(简称:仙乐健康,300791.SZ)递表港交所主 板,中信证券为其独家保荐人。 据了解,仙乐健康是领先的营养健康食品解决方案供应商,公司在2024年全球营养健康食品解决方案市 场中按收入计排名第三,并在中国营养健康食品解决方案市场中位居第一。此外,按2024年的收入计, 亦为全球第二大以软糖及软胶囊为基础的营养健康食品解决方案供应商。立足于潜力巨大的营养健康食 品解决方案市场,公司的业务表现实现稳健增长并保持可持续发展。仙乐健康作为营养健康食品解决方 案市场的先驱,已建立全球业务布局,拥有全球整合且于本地快速响应的生产基地、研发中心及供应链 体系网络。强大的研发与供应链能力,结合全球资源支撑的卓越营运效率,使公司能够持续为全球客户 提供端到端的解决方案,涵盖市场洞察、定制化解决方案、差异化研发、全球生产能力、全行业协作及 营销赋能。 财务资料: 根据招股书披露显示,于往绩记录期间,仙乐健康的收入及毛利录得强劲增长。收入由2023年的人民币 3,582.0百万元增加17.6%至2024年的人民币4,211.1百万元。收入亦由截至 2024年9月30日止九个月的 ...
港股公司回A升温 “H转深A”新案例已在路上
Zheng Quan Shi Bao· 2025-12-30 18:09
12月29日,来自深圳的港股机器人企业越疆宣布,启动首次公开发行人民币普通股及于深交所上市计 划。 从已经登陆科创板的百奥赛图再到映恩生物、光大环境等港股企业启动A股上市计划,港股近期掀起一 股积极"回A"的浪潮。值得关注的是,光大环境、越疆均为粤港澳大湾区企业,伴随着企业"回A"进程 的推进,"H转深A"有望增添新的示范案例,进一步探索并完善该通道的具体实践路径。 今年以来,A股公司赴港上市的趋势仍在延续,与此同时,港股企业回归A股市场也在不断升温。 12月10日,百奥赛图正式登陆科创板,继2022年在港交所上市后,百奥赛图正式迈入"A+H"双上市通 道。除此以外,今年4月在港交所上市的映恩生物,于11月完成科创板上市辅导备案,正式启动回A进 程;全球最大垃圾发电投资运营商光大环境今年11月公告拟发行不超过8亿股,计划登陆深交所,公司 已经于12月25日正式启动上市辅导。 资料显示,越疆是专门从事协作机器人开发、制造及商业化的领先企业之一,是蓬勃发展的具身智能机 器人行业前沿参与者,产品已广泛应用于工业制造、医疗手术等领域,覆盖全球超过100个国家和地 区。记者了解到,目前,越疆已委聘上市前辅导机构,并已提 ...
南华期货登陆港交所
Qi Huo Ri Bao Wang· 2025-12-23 02:01
Core Viewpoint - Nanhua Futures has successfully listed on the Hong Kong Stock Exchange, achieving an "A+H" dual listing, marking a significant milestone in its capital market strategy [1] Group 1: Listing Details - Nanhua Futures raised a total of HKD 1.203 billion through this listing [1] - The listing follows the precedent set by Hongye Futures, making Nanhua Futures the second futures company to achieve an "A+H" dual capital platform [1] Group 2: Fund Utilization - The net proceeds from the global offering will be allocated entirely to Henghua International [1] - The company aims to use the funds to expand its overseas business, optimize its business structure, and enhance its competitiveness and risk management capabilities in the global market [1]
招股两日认购寡淡,南华期货(02691)怎么了?
智通财经网· 2025-12-16 00:55
Core Viewpoint - The cold reception of Nanhua Futures' IPO in the Hong Kong market contrasts sharply with the high subscription rates of other companies, indicating a significant divergence in investor sentiment and highlighting concerns over the company's growth potential and valuation [1][12]. Company Overview - Nanhua Futures, established in 1996, is one of the first companies in China's futures industry and became the first A-share listed futures company in August 2019. The upcoming Hong Kong listing will make it the second futures company to achieve a dual listing in both A and H shares [2]. Financial Performance - Nanhua Futures ranked eighth among all futures companies in China by total revenue in 2024, with a revenue of 5.7 billion RMB, representing a market share of 2.1% among non-financial institution-related futures companies [3][2]. - The company's operating income is projected to grow from 9.54 billion RMB in 2022 to 13.55 billion RMB in 2024, but the growth rate is expected to slow significantly from 35.5% in 2023 to 4.8% in 2024 [5][6]. Revenue Structure - The decline in revenue growth is attributed to a decrease in commission rates for domestic futures brokerage services, with net commission and fee income expected to drop by 11.3% to 542 million RMB in 2024 [7]. - The average brokerage commission rate for domestic futures brokerage services fell from 0.334 basis points in 2023 to 0.158 basis points in the first half of 2025, leading to a decrease in operating profit margin from 18.6% to 6.2% [7]. Market Positioning - The pricing and terms of Nanhua Futures' IPO have dampened investor enthusiasm, with the offering price range set at 12-16 HKD, which represents a discount of approximately 33.7% compared to its A-share price [8]. - Compared to its peer Hongyi Futures, which has a much lower H/A ratio, Nanhua's offering does not present a compelling valuation advantage for investors seeking arbitrage opportunities [9]. IPO Mechanism - The IPO employs a fixed proportion and no reallocation mechanism, resulting in a lower expected allocation for retail investors, which diminishes their participation interest [10]. - The absence of cornerstone investors in the IPO increases market uncertainty, as there is no long-term capital to stabilize the stock price post-listing [10]. Market Sentiment - The overall cold reception of Nanhua Futures' IPO reflects a broader trend in the Hong Kong market, where investors are favoring companies with high growth potential and reasonable valuations, while remaining cautious towards those with short-term concerns [12].